QIAGEN

QIAGEN is a global life sciences company operating under the vision of "Making improvements in life possible." Headquartered with subsidiaries in 25 countries and serving more than 500,000 customers worldwide, QIAGEN provides end-to-end Sample to Insight solutions — products, instruments, and services that enable customers to extract meaningful insights from biological samples quickly, confidently, and accurately. The company's customer base spans young scientists, pharmaceutical R&D teams, clinical laboratories, and more than 35 Nobel Prize winners, all relying on QIAGEN technologies to advance science and improve patient outcomes.

QIAGEN's guiding principles are captured in the acronym QIA — Quality, Ingenuity and Accessibility — reflecting its commitment to excellence, creative problem-solving, and genuine partnership with customers. With a global workforce representing approximately 75 nationalities, QIAGEN combines deep scientific expertise with a broad international presence to address some of the most urgent challenges in healthcare, including combating cancer, diagnosing infectious diseases, ensuring public safety, and maintaining a reliable food supply.

Diagnostics and Clinical Solutions

• TB Management: QuantiFERON-TB Gold Plus for tuberculosis detection, including applications relevant to global travel and transplant settings via QuantiFERON Transplant.
• Infectious Disease: QIAstat-Dx Syndromic Testing for rapid, multiplex identification of infectious disease pathogens.
• Oncology: therascreen solid tumor assays, ipsogen leukemia testing, circulating tumor cell analysis, and DNA damage response solutions for comprehensive cancer diagnostics and research.
• Sexual and Reproductive Health: Cervical cancer screening, maternal/fetal testing, and STI testing solutions.
• Transplant and Viral Load Monitoring: artus Viral Load assays supporting transplant patient management.
• Solutions for Laboratory-Developed Tests: Dedicated offerings to support labs building and validating their own diagnostic assays.

Research and Discovery Solutions

• Next-Generation Sequencing (NGS): Comprehensive NGS workflows supporting applications such as cancer research, T-cell receptor specificity studies using machine learning, and large-scale genomic studies.
• Single-Cell Sequencing: Following the acquisition of Parse Biosciences, QIAGEN now offers scalable Evercode single-cell sequencing workflows that enable large studies without the need for specialized instruments.
• Sample Processing: A broad portfolio of kits and instruments for nucleic acid extraction and purification from diverse sample types.
• Instruments and Automation: Integrated instrument platforms designed to streamline and automate laboratory workflows.
• Informatics and Data: Bioinformatics tools and digital platforms to support data analysis and interpretation across research and clinical applications.

Digital Tools and Workflow Support

• Workflow Configurator / Experiment Configurator: An interactive digital tool that helps researchers design experimental workflows and identify the right products for their specific needs.
• Product Finder: A discovery tool enabling customers to quickly locate relevant products across QIAGEN's extensive portfolio of kits, instruments, and bioinformatics solutions.
• My QIAGEN Portal: A personalized online account platform providing access to orders, account management, and tailored support resources.

Services and Support

• Service Solutions: Dedicated service offerings to support instrument maintenance, laboratory operations, and customer success.
• Knowledge Hub: A centralized resource for scientific content, protocols, and technical guidance.
• Events and Webinars: Educational programming to keep customers informed on the latest scientific developments and product innovations.
• Product and Technical Support: Comprehensive support including Safety Data Sheets, Product FAQs, and ordering assistance.
• Quality, Environmental, Health and Safety (QEHS): A formal commitment to quality management and responsible operations across all business activities.

Strategic Focus Areas and Partnerships

• QIAGEN serves customers across discovery and translational research, diagnostics and clinical research, and human identification and forensics.
• The company maintains strategic partnerships to expand its reach and capabilities across applied, industrial, research, and clinical markets.
• QIAGEN's global presence enables it to meet local market needs while participating in international scientific collaboration, with particular focus on infectious disease testing, oncology, and genetic research.
• Customer stories highlight real-world impact, including early detection efforts for pancreatic cancer, tuberculosis management in the context of global travel, and machine learning applications in immunology research.

With a core portfolio comprising hundreds of kits, instruments, and bioinformatics tools, and a global team of thousands of employees across 25 countries, QIAGEN continues to serve as a trusted partner in progress — helping scientists, clinicians, and researchers unlock the insights hidden in DNA and RNA to improve lives around the world.